InStar Technologies is a biopharmaceutical company at the forefront of revolutionizing the Oral Thin Film (OTF) market with their innovative InStrip Technology. They enable the oromucosal delivery of a wide range of active substances, including nutraceuticals, small molecules, peptides, proteins, and vaccine antigens. With their patient-centric approach, InStar is reshaping the treatment of various health diseases.

The remarkable versatility of InStrip Technology opens up new possibilities for OTF products, overcoming the main obstacles faced by current technologies. It offers the ability to adjust the pharmacokinetics of active substances and allows for the needle-free administration of hormones, biologics, and biosimilars. Led by their experienced Chief Technology Officer, Dr.

Denisa Stranska, InStar's dedicated team has developed and patented this disruptive technology, making them a unicorn in the OTF industry. Their expertise extends across different biomedical sectors, ensuring the development and production of high-quality products. The advantages of InStrip technology are numerous, including accurate dosage, combination of different substances, high homogeneity and stability, and no water needed for administration.

With tailored release times and non-invasive delivery, InStrip technology offers easy and fast administration, making it suitable for a wide range of applications. Join InStar in revolutionizing healthcare with their groundbreaking Oral Thin Film technology